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Introduction
The human gastrointestinal tract hosts a very rich and
complex microbiota. Major dysfunctions of the gastroin-
testinal tract are related to intestinal microbiota aberran-
cies (Guarner and Malagelada 2003). Such disturbances
indicate potential targets for further research and clinical
applications. However, understanding the role of the
microbiota in these dysfunctions has been limited because
of the laboriousness and poor accuracy of the traditional
culture-dependent techniques. The application of molecu-
lar biology has allowed the development of alternative
culture-independent methods. The utilization of 16S
rRNA-targeted hybridization probes has permitted the cul-
ture-independent quantitative analysis of the microbiota by
means of fluorescence in situ hybridization (FISH) (Franks
et al. 1998; Harmsen et al. 2002). However, this technique
is very laborious and there are some difficulties for the vis-
ual counting of the samples, limiting its application. There-
fore, other quantitative methods facilitating rapid and
objective counting of a large number of samples are nee-
ded. In this context, real-time PCR is a promising tool to
study the composition of such complex communities as the
gastrointestinal tract. The development of real-time quanti-
tative PCR methods could lead to a thorough knowledge
about gut microbiota, relation with the diet and its role in
health and disease, and would provide a useful tool for clin-
ical assessment of probiotics/prebiotics efficacy.
Bifidobacterium is one of the predominant human faecal
organisms and several health-promoting properties have
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Abstract
Aim: To develop real-time quantitative PCR methods, based on the use of
probes labelled with a stable fluorescent lanthanide chelate, for the quantifica-
tion of different human faecal bifidobacterial populations.
Methods and Results: The designed quantitative PCR assays were found to
be specific for the corresponding Bifidobacterium species or groups (Bifido-
bacterium longum group, Bifidobacterium catenulatum group, Bifidobacterium
adolescentis, Bifidobacterium breve, Bifidobacterium angulatum, Bifidobacterium
bifidum and Bifidobacterium dentium). The detection limits of the methodolo-
gies used ranged between 2 · 105 and 9 · 103 cells g)1 of faeces. The applica-
bility of the developed assays was tested by analysing 20 human faecal samples.
Bif. longum group was found to be the qualitatively and quantitatively predom-
inant bifidobacterial group.
Conclusions: The real-time PCR procedures developed here are specific, accu-
rate, rapid and easy methods for the quantification of Bifidobacterium groups
or species in human faecal samples.
Significance and Impact of the Study: The developed procedures will facilitate
rapid and objective counting of large numbers of samples increasing our know-
ledge on the role of gut bifidobacterial microbiota in health and disease. This
will contribute to the efficient use of intestinal bacterial assays in research, food
and pharmaceutical development as well as in the assessment of dietary man-
agement of diseases.
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been attributed to this genus. Several culture-dependent
techniques have been used for the identification and typifi-
cation of bifidobacterial isolates (Gueimonde et al. 2004a;
Kwon et al. 2005; Krizova et al. 2006). Qualitative and
quantitative differences in the Bifidobacterium microbiota
composition of allergic and healthy children have been
reported (Kallioma¨ki et al. 2001; Ouwehand et al. 2001).
A number of real-time PCR assays have been developed
for the quantification of members of the genus Bifidobacte-
rium (Gueimonde et al. 2004b; Matsuki et al. 2004; Haar-
man and Knol 2005; Lahtinen et al. 2005). The TaqMan
quantitative PCR assay has been used for the quantifica-
tion of Bifidobacterium (Requena et al. 2002; Penders et al.
2005) and some bifidobacterial groups or species (Malinen
et al. 2003; Haarman and Knol 2005) in faecal samples.
Also SYBR Green based assays have been used for PCR
quantification of bifidobacterial species or groups (Malin-
en et al. 2003; Matsuki et al. 2004).
In this work we have developed real-time PCR assays
for the quantification of different intestinal Bifidobacteri-
um species or groups by using a different real-time PCR
approach. The developed assays are based on the use of
environmentally sensitive lanthanide chelates and the 5¢-3¢
exonucleolytic activity of the DNA polymerase. This
methodology has previously been proved to be very
reproducible and accurate for the quantification of the
total number of bifidobacteria in faeces (Gueimonde et al.
2004b).
Materials and methods
Bacterial strains and growth conditions
The strains used in this study include the Bifidobacterium
strains shown in Table 1 as well as an array of another 21
intestinal and food related bacteria, including members of
the genera Bacteroides, Clostridium, Enterobacter, Entero-
coccus, Escherichia, Eubacterium, Lactobacillus, Peptostrep-
tococcus, Anaerococcus, Ruminococcus, Streptococcus and
Veillonella (data not shown). Strains were grown in GAM
broth or agar (Nissui Pharmaceutical Co., Tokyo, Japan)
and incubated at 37C in a Concept 400 anaerobic cham-
ber (Ruskinn Technology, Leeds, UK).
Oligonucleotides
PCR primers targeting different Bifidobacterium species or
groups were used (Table 2). The specificity of these prim-
ers has been previously reported (Rinne et al. 2005). In
addition, in order to run quantitative PCR assays based
on the 5¢-3¢ exonucleolytic activity of the DNA polym-
erase internal oligonucleotide probes were designed
(Table 2). To check the specificity of the designed probes Ta
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the sequences were compared with the sequences available
in both the BLAST database search program (http://
www.ncbi.nlm.nih.gov/BLAST) (Altschul et al. 1997) and
the Ribosomal Database Project II (http://www.rdp.
cme.msu.edu/html) (Cole et al. 2003). Oligonucleotide
primers and probes used were purchased from Thermo
Electron Corporation (Thermo Biosciences, Ulm, Ger-
many). The probes were labelled postsynthetically with an
isothiocyanate-modified stable, fluorescent europium che-
late as described by Nurmi et al. (2002). In this way sets
of specific primers and probes were developed for Bifido-
bacterium longum group, Bifidobacterium catenulatum
group, Bifidobacterium dentium, Bifidobacterium bifidum,
Bifidobacterium angulatum, Bifidobacterium adolescentis
and Bifidobacterium breve (Table 2).
Bifidobacterium species-specific real-time PCR assays
To test the specificity of the primers-probes sets, DNA
was extracted from pure cultures of the different micro-
organisms as previously described (Gueimonde et al.
2004b) and stored at )20C until its use.
Amplification of the DNA was performed in a PCR iCy-
cler apparatus (BioRad, Espoo, Finland). The PCR reaction
mixture was composed of 50 ll amplification reactions
consisting of 1 · PCR buffer II, 3Æ5 mmol l)1 MgCl2,
0Æ2 lmol l)1 of each primer, 200 lmol l)1 of each dNTP,
0Æ024 lmol l)1 europium-labelled probe, 0Æ166 lmol l)1
quencher probe and 1Æ25 U of AmpliTaq Gold DNA
polymerase (Applied Biosystems, Espoo, Finland). 2 ll of
DNA extract (30 ng) was used as the template. Thermal
cycling (iCycler) consisted of the following time and tem-
perature profile: an initial cycle of 95C 10 min, 40 cycles
of 95C 15 s, 90 s at the corresponding annealing tempera-
ture (Table 2) and 35C 15 s. Europium fluorescence
measurements were performed in real-time at the end of
each cycle, using a Wallac Victor 1420 Multilabel Counter
(Perkin Elmer, Turku, Finland) at 35C.
Analysis of faecal samples by quantitative real-time PCR
A total of 20 human faecal samples, corresponding to
eight infants (<2 years), eight adults (20–40 years) and
four elderly people (>70 years) were included in this
Table 2 Oligonucleotides and annealing temperatures (T a) used in this study
Oligo Sequence (5¢ ﬁ 3¢)* T a Specificity
Primer 5¢ TTCCAGTTGATCGCATGGTCTTCT 65 Bifidobacterium longum group
Primer 3¢ GGCTACCCGTCGAAGCCACG
Probe EGCGACCCCATCCCATACCGCGATT
Quencher ATGGGATGGGGTCGCD
Primer 5¢ GGATCGGCTGGAGCTTGCTCCG 63 Bifidobacterium adolescentis
Primer 3¢ CCCCGAAGGCTTGCTCCCAGT
Probe ECTCCAGTTGGATGCATGTCCTTCTGGCT
Quencher TGCATCCAACTGGAGD
Primer 5¢ AATGCCGGATGCTCCATCACAC 62 Bifidobacterium breve
Primer 3¢ GCCTTGCTCCCTAACAAAAGAGG
Probe ECATGCCGCAAAGGCTTTCCCAACACTG
Quencher AGCCTTTGCGGCATGD
Primer 5¢ TGACCGACCTGCCCCATGCT 61 Bifidobacterium bifidum
Primer 3¢ CCCATCCCACGCCGATAGAAT
Probe ETGTTCCACATGATCGCATGTGATTGTGCC
Quencher CGATCATGTGGAACAD
Primer 5¢ GCCGGATGCTCCGACTCCT 64 Bifidobacterium catenulatum group
Primer 3¢ ACCCGAAGGCTTGCTCCCGAT
Probe ETACCGATGAAATCTTTCCCGACACCCGT
Quencher AAGATTTCATCGGTAD
Primer 5¢ GGATCGGCTGGAGCTTGCTCCG 66 Bifidobacterium angulatum
Primer 3¢ TCACCCGAAGGCTTGCTCCCCAA
Probe EATCTTTCCCAGACCACCATGCGATGGACAC
Quencher TGGTCTGGGAAAGATD
Primer 5¢ ATCCCGGGGGTTCGCCTCC 62 Bifidobacterium dentium
Primer 3¢ ATACCGATGGAACCTTTCCCGG
Probe ETGCTCCGGTTGGATGCATGTCCTTCCCC
Quencher CATCCAACCGGAGCAD
*Bold letters indicate bases that are not complementary to the target. E2,2¢,2¢¢,2¢¢¢-[2-(4-Isothiocyanatophenyl) ethylimino]bis (methylene)bis4-[4-
(a-galactopyranoxy)phenyl] ethynylpyridine-6,2-diylbis (methylene–nitrilo)tetrakis(acetato)europium (III). DDabcyl.
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study. Faecal specimens were immediately cooled to 4C
after collection, delivered within 24 h, and frozen at
)75C directly on receipt until analysis. One gram of fae-
cal material was weighted and homogenized with 9 ml of
PBS buffer in a Stomacher 400 (Seward Ltd., London,
UK) at full speed for 2 min. 200 ll of the homogenate
were used for the DNA extraction by using the QIAamp
DNA stool Mini kit (Qiagen, Hilden, Germany) following
the manufacturer’s instructions. For standard curves, dif-
ferent dilutions of microbial cultures of the appropriate
bifidobacterial species shown in Table 1 (cell numbers
ranging from 1Æ5 · 104 to 9Æ8 · 109 cells ml)1) were used
for the DNA extraction with the QIAamp DNA stool Mini
Kit (Qiagen). Standard curves were made by plotting the
Ct values obtained for the standard cultures as a linear
function of the base-10 logarithm of the initial number
of cells, of the corresponding bifidobacterial species
(Table 1), in the culture determined by plate counting.
Samples (2 ll) were analysed in 50 ll amplification
reactions with the conditions described above. Europium
fluorescence measurements were performed in real-time at
the end of each cycle to determine the threshold cycles (Ct)
of individual reactions. The Ct was defined as the PCR
cycle at which the europium signal-to-noise ratio (S/N)
crosses a threshold value of 1Æ2. The numbers of cells of
the different Bifidobacterium species or groups in the faecal
samples were determined by comparing the Ct values
obtained to the standard curve. DNA extracts from the dif-
ferent samples were analysed in duplicate in each PCR in
at least two independent PCR runs. Levels of total bifido-
bacteria were determined by using the genus-specific meth-
odology previously described (Gueimonde et al. 2004b).
Statistical analysis
Statistical analysis was carried out using the SPSS 11Æ0
software (SPSS Inc., Chicago, IL, USA). Data were subjec-
ted to one-way anova using the subject group as factor
with three categories; infants, adults and elderly. The least
significant difference (LSD) test was used for comparison
of means.
Results
Bifidobacterium species-specific quantitative PCR assays
Table 1 shows the results of the test of the specificity of
the developed assays obtained by using the primers,
probes and annealing temperatures shown in Table 2. All
non-bifidobacterial strains tested showed no amplification
with any of the bifidobacterial species-specific assays (data
not shown) and all the assays were specific for the Bifido-
bacterium species for which they were developed, inclu-
ding, Bif. longum group, Bif. catenulatum group, Bif.
dentium, Bif. bifidum, Bif. angulatum, Bif. adolescentis and
Bif. breve.
For the standard curves, the results obtained (Ct val-
ues) for each species or group were plotted against the
initial number of cells in the corresponding culture (data
not shown). In all the assays the results were found to be
linear over the range of cell concentrations tested (104–
1010 cells ml)1). The coefficients of determination (R2)
obtained for the different standard curves ranged from
0Æ991 to 0Æ999 and the slopes varied between )3Æ28 and
)3Æ60, corresponding with PCR efficiencies of between
99% and 91%, respectively. On the other hand, the detec-
tion limits of the different specific real-time PCR proce-
dures, following the DNA extraction and PCR conditions
described here, ranged from 2 · 105 to 9 · 103 cells g)1.
A high reproducibility was observed for our quantitative
PCR assays, which is in accordance with the results
obtained by other researchers (Huijsdens et al. 2002; Gue-
imonde et al. 2004b).
Quantification of bifidobacterial species or groups
in faecal samples
To test the applicability of the developed methods human
faecal samples were analysed (Table 3). The presence of
PCR inhibitors in the negative samples was tested by con-
ducting a real-time PCR with a DNA extract positive for
the corresponding species or group in the presence of
2 ll of DNA extract from the problem sample. The fluor-
escent signal was the same for the control sample in the
presence or absence of DNA extract from the problem
samples indicating that there were no PCR inhibitors in
those DNA extracts.
In the samples containing Bifidobacterium the average
number of different bifidobacterial species or groups
detected was 2Æ15 ± 0Æ76. Table 4 shows the prevalence
and levels of the different bifidobacterial species or groups
in infants, adults and elderly subjects. Although the num-
ber of samples analysed does not allow us to establish
firm conclusions, Bif. longum group was the most widely
found and the most numerous in 11 of 19 samples har-
bouring bifidobacteria, representing a 27Æ2% ± 22% of
the total bifidobacterial population. Bifidobacterium caten-
ulatum was the most numerous group in four samples,
Bif. breve was the predominant species in two samples
whilst Bif. bifidum and Bif. dentium were predominant in
one sample each (Table 3).
Interestingly, the levels of total bifidobacteria and
members of Bif. longum group were significantly higher
(P < 0Æ05) in infants than in adults or elderly faeces. No
statistically significant differences were found for any of
the other groups analysed.
M. Gueimonde et al. PCR quantification of Bifidobacterium species
ª 2006 The Authors
Journal compilation ª 2006 The Society for Applied Microbiology, Journal of Applied Microbiology 102 (2007) 1116–1122 1119
By using the seven species/group specific real-time PCR
procedures described here it was possible to quantify
almost 50% (average, 49%) of the total number of bifido-
bacteria detected with the genus specific quantitative PCR
method, indicating that probably there are still other bifi-
dobacterial species or groups present in these samples.
Discussion
It has previously been shown that more than 60% of the
intestinal bacteria cannot usually be cultivated (Suau et al.
1999). With regard to bifidobacteria, important differ-
ences have been observed when comparing culture-
dependent and culture-independent methods (Apajalahti
et al. 2003), indicating the limitations of the former for
the study of the intestinal microbiota and the need of
easy, accurate and rapid culture-independent methods.
In this study easy, rapid and accurate culture-inde-
pendent real-time PCR methods, based on the use of
lanthanide chelates, combining the high specificity of
fluorescent oligonucleotides and the sensitivity of PCR,
were developed and used for the quantification of Bifido-
Table 3 Faecal levels (Log n cells g)1) of the different Bifidobacterium species/groups tested as determined by the quantitative PCR procedures
Sample Genus
Bifidobacterium
longum
Bifidobacterium
bifidum
Bifidobacterium
breve
Bifidobacterium
catenulatum
Bifidobacterium
adolescentis
Bifidobacterium
angulatum
Bifidobacterium
dentium
I1 10Æ04 ± 0Æ20 9Æ30 ± 0Æ10 8Æ91 ± 0Æ07 8Æ67 ± 0Æ04 – – – –
I2 9Æ97 ± 0Æ06 8Æ72 ± 0Æ05 8Æ13 ± 0Æ09 8Æ94 ± 0Æ09 – – – –
I3 9Æ98 ± 0Æ06 9Æ57 ± 0Æ29 – – 5Æ98 ± 0Æ02 – – –
I4 9Æ64 ± 0Æ11 8Æ86 ± 0Æ17 – – 9Æ49 ± 0Æ17 – – –
I5 9Æ69 ± 0Æ09 9Æ52 ± 0Æ06 – – 8Æ32 ± 0Æ04 – – –
I6 9Æ97 ± 0Æ11 8Æ74 ± 0Æ08 – – – – – –
I7 9Æ31 ± 0Æ07 7Æ68 ± 0Æ5 – – – 6Æ24 ± 0Æ30 – –
I8 9Æ23 ± 0Æ06 8Æ95 ± 0Æ04 7Æ43 ± 0Æ12 – 8Æ38 ± 0Æ01 6Æ93 ± 0Æ09 – –
A1 9Æ10 ± 0Æ05 8Æ14 ± 0Æ11 – – 8Æ19 ± 0Æ12 – – –
A2 9Æ18 ± 0Æ03 8Æ19 ± 0Æ10 – – 7Æ92 ± 0Æ02 – – –
A3 8Æ66 ± 0Æ14 7Æ21 ± 0Æ03 – – 7Æ83 ± 0Æ04 – – –
A4 – – – – – – – –
A5 8Æ78 ± 0Æ09 8Æ52 ± 0Æ10 – – – – – –
A6 9Æ12 ± 0Æ06 8Æ40 ± 0Æ02 – – – 7Æ45 ± 0Æ18 – –
A7 8Æ96 ± 0Æ05 8Æ71 ± 0Æ06 8Æ14 ± 0Æ08 – – – – –
A8 8Æ31 ± 0Æ06 8Æ03 ± 0Æ07 – 8Æ70 ± 0Æ14 – – – –
E1 8Æ37 ± 0Æ02 7Æ95 ± 0Æ03 – – 7Æ58 ± 0Æ03 – – –
E2 9Æ80 ± 0Æ03 – – – 7Æ72 ± 0Æ07 – 8Æ5 ± 0Æ12 9Æ22 ± 0Æ05
E3 8Æ68 ± 0Æ01 7Æ69 ± 0Æ10 7Æ17 ± 0Æ02 – 7Æ88 ± 0Æ04 – – –
E4 6Æ60 ± 0Æ11 – 6Æ72 ± 0Æ10 – – – – –
Table 4 Prevalence and levels (Log
n cells g)1) of the different bifidobacterial
species and groups analysed in the studied
subjects
Bifidobacteria Infants Adults Elderly
Genus Prevalence 8/8 7/8 4/4
Mean (SD) 9Æ74 (0Æ30)b 8Æ88 (0Æ31)a 8Æ37 (1Æ31)a
Bifidobacterium longum group Prevalence 8/8 7/8 2/4
Mean (SD) 8Æ92 (0Æ60)b 8Æ17 (0Æ48)a 7Æ82 (0Æ18)a
Bifidobacterium bifidum Prevalence 3/8 1/8 2/4
Mean (SD) 8Æ16 (0Æ74) 8Æ14 (0Æ00) 6Æ93 (0Æ33)
Bifidobacterium breve Prevalence 2/8 1/8 0/4
Mean (SD) 8Æ80 (0Æ19) 8Æ4 (0Æ00) –
Bifidobacterium catenulatum group Prevalence 4/8 3/8 3/4
Mean (SD) 8Æ04 (1Æ47) 7Æ98 (0Æ19) 7Æ73 (0Æ15)
Bifidobacterium adolescentis Prevalence 2/8 1/8 0/4
Mean (SD) 6Æ58 (0Æ49) 7Æ45 (0Æ00) –
Bifidobacterium angulatum Prevalence 0/8 0/8 1/4
Mean (SD) – – 8Æ50 (0Æ00)
Bifidobacterium dentium Prevalence 0/8 0/8 1/4
Mean (SD) – – 9Æ22 (0Æ00)
Means with different superscripts in the same row differ significantly (P < 0Æ05).
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bacterium species or groups in faecal samples. A good
correlation has been previously shown between results
obtained by this quantitative real-time PCR methodology
and those obtained by FISH, the considered golden stand-
ard for intestinal bacteria quantification (Gueimonde
et al. 2004b).
The specificity of the assays was shown by testing them
with a collection of intestinal and food bacteria. Taking
into account that specific probes were used together with
the Bifidobacterium species-specific primers, a high specif-
icity can be expected. Furthermore, the low detection lim-
its (£105) obtained by using the DNA extraction and
PCR conditions described in this study, and taking into
account that they could be improved by adjusting the
number of PCR cycles or concentrating the extracted
DNA, seems to demonstrate that these methods have
potential for a very high sensitivity.
To test the applicability of these methods 20 human
faecal samples from infants, adults and elderly persons
were analysed. In general, the levels of total Bifidobacteri-
um as well as those of the different bifidobacterial species
or groups were in the range of those previously reported
(Gueimonde et al. 2004b; Matsuki et al. 2004; Haarman
and Knol 2005; Hopkins et al. 2005). The Bifidobacterium
levels observed in infants were significantly higher than
those found in adults. Differences between infants and
adults were also found in the level of members of Bif. lon-
gum group. In accordance with previous reports (Matsuki
et al. 1999; Haarman and Knol 2005) our study demon-
strates that micro-organisms belonging to Bif. longum
group (including Bif. longum and Bifidobacterium infantis)
are the most widely found and the ones showing higher
levels in infant faeces. Contrary to this Matsuki et al.
(2004) found that in adults Bif. adolescentis, Bif. catenula-
tum and Bif. longum are the predominant species. In
agreement with our results they reported Bif. longum as
the most widely distributed species but Bif. adolescentis as
the numerically predominant species. In our study Bif.
longum and Bif. catenulatum were the most frequently
found species in adults but Bif. adolescentis was present in
only one sample. 16S rDNA sequence heterogeneity has
been reported in Bif. adolescentis (Matsuki et al. 2004).
Sequence divergences in the regions targeted by our oligo-
nucleotides could lead to a failure of the DNA amplifica-
tion and this could explain the lower prevalence and
levels of Bif. adolescentis observed in our study. Bacterial
quantification by real-time PCR can be influenced by dif-
ferences in the number of rRNA operons, sequence het-
erogeneity or differential amplification of different DNA
molecules (Schmalenberger et al. 2001). Mainly the rDNA
genes are being used as the target molecules, but as more
bacterial sequences are becoming available, new specific
primers and probes targeting other genes will be available
in the near future to be used in cases in which the 16S
rDNA is not an adequate target.
The seven species/group specific real-time PCR proce-
dures reported here allowed the identification and quanti-
fication of about half (average, 49%) of the total number
of bifidobacteria detected with the genus specific quanti-
tative PCR method. This coverage is in good agreement
with the results obtained by Haarman and Knol (2005)
using primers specific for the same species but targeting
the rDNA intergenic region. These results appear to
indicate that there is still an important proportion of
bifidobacteria that cannot be detected and other Bifido-
bacterium species may be present in human faecal sam-
ples. In this regard, Bifidobacterium lactis has been
reported to be more common in human faeces than pre-
viously expected, indicating that certain species could
have been overlooked in the traditional culture studies
(Bartosch et al. 2005).
We conclude that the quantitative real-time PCR meth-
odologies described are accurate, rapid and easy methods
for the quantification of bifidobacterial groups or species
in human faeces. These methodologies will facilitate rapid
and objective counting of large numbers of samples con-
tributing to the efficient use of intestinal bacterial assays
in research, food and pharmaceutical development as well
as in the assessment of dietary management of diseases.
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